Try our Advanced Search for more refined results

Regents of the University of Minnesota v. Gilead Sciences, Inc.

  1. October 20, 2017

    Gilead Gets Hep C Drug Patent Suit Shipped To Calif.

    Gilead Sciences won its bid to transfer a patent infringement suit filed by the University of Minnesota over the company's blockbuster hepatitis C drugs to California on Friday when a Minnesota federal judge invoked a recent Federal Circuit ruling that says such actions can be filed only where a defendant has a long-standing physical location.

  2. August 31, 2016

    U. Of Minn. Says Gilead's $20B Hep C Drugs Flout Patent

    The University of Minnesota filed a patent infringement suit against Gilead Sciences in Minnesota federal court on Monday alleging the company's blockbuster hepatitis C drugs Sovaldi, Harvoni and Epclusa infringe a patent issued to a scientist at the university.